CLL
Feature
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...
From the Journals
Aspirin warning: Anemia may increase with daily use
“We found that low-dose aspirin also increased the risk of anemia during the trial, and this was most likely due to bleeding that was not...
Conference Coverage
CLL: Venetoclax-obinutuzumab combo effective long term
Progression-free survival benefit of 1 year with venetoclax-obinutuzumab is sustained long term in chronic lymphocytic leukemia, trial analysis...
Conference Coverage
Cancer drug shortages spur worry, rationing, and tough choices
Limited supplies of crucial medications are disrupting patient care, oncologists say.
From the Journals
Ibrutinib + venetoclax: High-risk features don’t lessen CLL response
Expert cautions that upfront targeted therapies for CLL should be considered experimental, given the adverse events and lack of long-term follow-...
Feature
Widespread carboplatin, cisplatin shortages: NCCN survey
Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.
Conference Coverage
`Remarkable’: CAR T therapy for CLL/SLL
Primary analysis of the TRANSCEND CLL 004 trial showed that a single dose of CAR T therapy achieved durable responses in CLL and SLL, with a...
Latest News
Oncologist pleads guilty to prescription drug fraud
Dr. Kachadourian was paid more than $170,000 for purchasing and allowing others to purchase in her name millions of dollars in prescription drugs...
From the Journals
New CLL meds: Improved survival rates, 1990-2018
A just-published retrospective study shows nearly 30 years of steady progress in lengthening the lives of U.S. adults with CLL and other leukemias...
From the Journals
Venetoclax boosts ibrutinib in high-risk CLL
Most patients in a small study reached undetectable measurable disease after taking combo therapy for high-risk CLL.
Latest News
Drug shortages in U.S. at 10-year high
Among the top five drug classes affected by shortages are chemotherapy drugs used in the treatment of cancer, many of which do not have...